CompletedNo phase
Prevalence of Ascending Aortic Dilation in Sports Medicine
Key facts
- Who runs it
- University Hospital, Caen
- Where
- France1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 400 people enrolled
- Started
- 1 Jan 2024
- Ended
- 1 Jun 2025
- Type of study
- Observational
- Treatments tested
- focused cardiac ultrasound
- Record updated
- 3 July 2025
Who can take part
- Age
- 10 years and older
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 9 criteriaShow less
Who can take part
- Individuals aged 10 years and older
- Consulting for a pre-participation sports medicine evaluation at the Caen University Hospital
- No known history of cardiovascular disease
- Underwent a focused cardiac ultrasound (FCU) of the ascending aorta as part of the consultation
- Consent given for use of anonymized medical data for research purposes
Who cannot take part
- Previous diagnosis of aortic disease or cardiovascular malformation
- Existing cardiology follow-up with echocardiography less than 3 years old
- Incomplete or non-interpretable FCU images
- Refusal to participate or opposition to data use
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This study aims to assess the prevalence of ascending aortic dilation in athletes from the general population undergoing routine sports medicine evaluation. It also evaluates the predictive factors and the reproducibility of focused cardiac ultrasound.
The group in the trial
- Recreational and competitive Athletes
All athletes aged over 10 years consulting for routine sports medicine evaluation, regardless of sport type or performance level.
Treatment: focused cardiac ultrasound
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Record updated
- 3 July 2025